Lindzon is touting this biotech stoke that is a spray to cure a sometimes deadly disease. FDA has put it on the fast track. What is the stock?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More InfoYour subscription is paid through your PayPal account.
To update your credit card or cancel, please log in to PayPal.com, go to your automatic payments, open the Stock Gumshoe payment, and make changes there.
More information here: Paypal — What Is an Automatic Payment and How Do I Update or Cancel One?
I could be complete wrong on this, but it sounds like Insys (INSY). Very beat-up MMJ stock that had some marketing misdeeds associated with it’s fentanyl drug. Meanwhile, they have a CBD mist in the pipeline. It is rare to see this kind of value with this kind of upside. Judge for yourself… https://globenewswire.com/news-release/2018/03/02/1414148/0/en/INSYS-Therapeutics-Initiates-Phase-3-Clinical-Trial-of-Cannabidiol-CBD-Oral-Solution-for-Treatment-of-Infantile-Spasms.html
The pitch clearly states this is supposed to treat the 7th leading cause of death among men. Rudimentary search comes up with diabetes. INSY’s spray is for infantile spasms.
Thanks, gentlemen.
http://www.investor.jnj.com/janssen-phase-3-study-programme-of-esketamine-nasal-spray-in-patients-with-treatment-resistant-depression-presented-for-the-first-time-in-europe
CDC 2015 says Suicide
I think it’s JNJ
https://www.cdc.gov/healthequity/lcod/men/2015/all-males/index.htm
I think it’s Depression, and the stock may be a household name like Johnson & Johnson…
Thoughts on VTGN Vistagen working on Esketamine for depression. JNJ is front runner with their subsidiary company.